NO893101L - Fremgangsmaate for fremstilling av laktamderivater. - Google Patents

Fremgangsmaate for fremstilling av laktamderivater.

Info

Publication number: NO893101L
Authority: NO; Norway
Prior art keywords: group; 4alkyl; hydrogen atom; 6alkyl; phenyl
Prior art date: 1988-08-02

Application number

NO89893101A

Other languages

English (en)

Other versions

NO169714B (no

NO169714C (no

NO893101D0 (no

Inventor

Ian Harold Coates

Alexander William Oxford

Peter Charles North

Barry John Price

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-08-02

Filing date

1989-08-01

Publication date

1990-02-05

1988-08-02 Priority claimed from GB888818393A external-priority patent/GB8818393D0/en

1989-02-23 Priority claimed from GB898904195A external-priority patent/GB8904195D0/en

1989-02-28 Priority claimed from GB898904550A external-priority patent/GB8904550D0/en

1989-08-01 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

1989-08-01 Publication of NO893101D0 publication Critical patent/NO893101D0/no

1990-01-31 Priority claimed from HU90608A external-priority patent/HU207078B/hu

1990-02-05 Publication of NO893101L publication Critical patent/NO893101L/no

1992-04-21 Publication of NO169714B publication Critical patent/NO169714B/no

1992-07-29 Publication of NO169714C publication Critical patent/NO169714C/no

Links

150000003951 lactams Chemical class 0.000 title abstract 2
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 7
125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 5
125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 5
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 4
125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 3
125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 abstract 3
-1 C3-6alkenyl Chemical group 0.000 abstract 3
125000005843 halogen group Chemical group 0.000 abstract 3
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 3
102000035037 5-HT3 receptors Human genes 0.000 abstract 1
108091005477 5-HT3 receptors Proteins 0.000 abstract 1
208000019901 Anxiety disease Diseases 0.000 abstract 1
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
208000028017 Psychotic disease Diseases 0.000 abstract 1
206010047700 Vomiting Diseases 0.000 abstract 1
125000000217 alkyl group Chemical group 0.000 abstract 1
239000005557 antagonist Substances 0.000 abstract 1
230000036506 anxiety Effects 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
229910052731 fluorine Inorganic materials 0.000 abstract 1
125000001153 fluoro group Chemical group F* 0.000 abstract 1
229910052739 hydrogen Inorganic materials 0.000 abstract 1
239000001257 hydrogen Substances 0.000 abstract 1
125000002883 imidazolyl group Chemical group 0.000 abstract 1
229910052757 nitrogen Inorganic materials 0.000 abstract 1
125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
230000003389 potentiating effect Effects 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
229920006395 saturated elastomer Polymers 0.000 abstract 1
239000012453 solvate Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Diabetes (AREA)
Hospice & Palliative Care (AREA)
Child & Adolescent Psychology (AREA)
Obesity (AREA)
Hematology (AREA)
Anesthesiology (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Otolaryngology (AREA)
Nutrition Science (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Cephalosporin Compounds (AREA)

NO893101A 1988-08-02 1989-08-01 Analogifremgangsmaate for fremstilling av terapeutisk aktive laktamderivater NO169714C (no)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
GB888818393A GB8818393D0 (en)	1988-08-02	1988-08-02	Chemical compounds
GB898904195A GB8904195D0 (en)	1989-02-23	1989-02-23	Chemical compounds
GB898904550A GB8904550D0 (en)	1989-02-28	1989-02-28	Chemical compounds
HU90608A HU207078B (en)	1988-08-02	1990-01-31	Process for producing lactam derivatives and pharmaceutical compositions comprising such compounds

Publications (4)

Publication Number	Publication Date
NO893101D0 NO893101D0 (no)	1989-08-01
NO893101L true NO893101L (no)	1990-02-05
NO169714B NO169714B (no)	1992-04-21
NO169714C NO169714C (no)	1992-07-29

Family

ID=27450153

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO893101A NO169714C (no)	1988-08-02	1989-08-01	Analogifremgangsmaate for fremstilling av terapeutisk aktive laktamderivater

Country Status (14)

Country	Link
EP (1)	EP0353983B1 (no)
JP (1)	JPH02160786A (no)
AT (1)	ATE138659T1 (no)
AU (1)	AU631131B2 (no)
CA (1)	CA1336906C (no)
DE (1)	DE68926553T2 (no)
DK (1)	DK169922B1 (no)
ES (1)	ES2088389T3 (no)
FI (1)	FI92067C (no)
GR (1)	GR3020349T3 (no)
IL (1)	IL91167A (no)
NO (1)	NO169714C (no)
NZ (1)	NZ230154A (no)
PT (1)	PT91336B (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ226032A (en) *	1987-09-03	1991-12-23	Glaxo Group Ltd	2-(imidazolylmethyl)-pyrido or-azepino(4,3-b)indole-1(2h)-one derivatives; preparatory processes and pharmaceutical compositions
GB8904551D0 (en) *	1989-02-28	1989-04-12	Glaxo Group Ltd	Chemical compounds
GB8904552D0 (en)	1989-02-28	1989-04-12	Glaxo Group Ltd	Chemical process
HU204049B (en) *	1989-02-28	1991-11-28	Glaxo Group Ltd	Process for producing lactam derivatives and pharmaceutical compositions comprising same
GB8928208D0 (en) *	1989-12-13	1990-02-14	Glaxo Group Ltd	Medicaments
GB9011469D0 (en) *	1990-05-23	1990-07-11	Glaxo Group Ltd	Chemical process
US5102889B1 (en) *	1990-09-27	1993-05-11		2-(4-piperidinyl)-1h-pyrido(4,3-b)indol-1-ones and related compounds
US5229517A (en) *	1990-09-27	1993-07-20	Hoechst-Roussel Pharmaceuticals Incorporated	2-(4-Piperindinyl)-1H-pyrido[4,3-B]indol-1-ones and related compounds
HU211081B (en) *	1990-12-18	1995-10-30	Sandoz Ag	Process for producing indole derivatives as serotonin antagonists and pharmaceutical compositions containing the same
GB9216154D0 (en) *	1992-07-30	1992-09-09	Glaxo Group Ltd	Chemical compounds
EP0581388A1 (en) *	1992-07-30	1994-02-02	Glaxo Group Limited	Pyridoindolone Methansulphonate as 5HT and 5HT3 receptor antagonists
CA2212092A1 (en) *	1995-12-01	1997-06-12	Makoto Shibata	Pyrroloazepine derivatives
AU2001234958A1 (en) *	2000-02-11	2001-08-20	Bristol-Myers Squibb Company	Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators for treating respiratory and non-respiratory diseases
WO2003014118A1 (en) *	2001-08-08	2003-02-20	Pharmacia & Upjohn Company	THERAPEUTIC 1H-PYRIDO[4,3-b]INDOLES
US6770655B2 (en)	2002-01-18	2004-08-03	Aryx Therapeutics	5-HT3 receptor antagonists and methods of use
GB0305553D0 (en) *	2003-03-11	2003-04-16	Glaxo Group Ltd	Compounds
CA2629077C (en)	2005-11-16	2014-03-18	F. Hoffmann-La Roche Ag	Novel process for the preparation of thoc
RU2007139634A (ru) *	2007-10-25	2009-04-27	Сергей Олегович Бачурин (RU)	Новые тиазол-, триазол- или оксадиазол-содержащие тетрациклические соединения
EP2424366B1 (en)	2009-04-29	2016-02-17	Medivation Technologies, Inc.	Pyrido [4, 3-b]indoles and methods of use
EP2424364A4 (en)	2009-04-29	2012-12-19	Medivation Technologies Inc	PYRIDO [4.3-B] INDOLES AND METHODS OF USE
ES2664599T3 (es)	2009-05-20	2018-04-20	INSERM (Institut National de la Santé et de la Recherche Médicale)	Antagonistas del receptor 5-HT3 de serotonina para uso en el tratamiento de trastornos vestibulares lesionales
EP2253316B1 (en)	2009-05-20	2013-08-14	INSERM (Institut National de la Santé et de la Recherche Médicale)	Serotonin 5-HT3 receptor antagonists for use in the treatment or prevention of an inner ear pathology with vestibular deficits
BR112013021126A2 (pt)	2011-02-18	2019-09-24	Medivation Technologies Inc	método para reduzir a pressão sanguínea, método para aumentar o fluxo sanguíneo renal ou diminuir a reabsorção de sódio, método para tratar uma doença, kit, composto e composição farmacêutica

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GR871809B (en) *	1986-11-28	1988-03-07	Glaxo Group Ltd	Process for the preparation of tricyclic ketones
NZ226032A (en) *	1987-09-03	1991-12-23	Glaxo Group Ltd	2-(imidazolylmethyl)-pyrido or-azepino(4,3-b)indole-1(2h)-one derivatives; preparatory processes and pharmaceutical compositions
HU204049B (en) *	1989-02-28	1991-11-28	Glaxo Group Ltd	Process for producing lactam derivatives and pharmaceutical compositions comprising same

1989
- 1989-08-01 AU AU39186/89A patent/AU631131B2/en not_active Ceased
- 1989-08-01 NO NO893101A patent/NO169714C/no unknown
- 1989-08-01 DE DE68926553T patent/DE68926553T2/de not_active Expired - Fee Related
- 1989-08-01 NZ NZ230154A patent/NZ230154A/xx unknown
- 1989-08-01 ES ES89307788T patent/ES2088389T3/es not_active Expired - Lifetime
- 1989-08-01 CA CA000607219A patent/CA1336906C/en not_active Expired - Fee Related
- 1989-08-01 AT AT89307788T patent/ATE138659T1/de not_active IP Right Cessation
- 1989-08-01 JP JP1200177A patent/JPH02160786A/ja active Pending
- 1989-08-01 IL IL91167A patent/IL91167A/xx not_active IP Right Cessation
- 1989-08-01 FI FI893634A patent/FI92067C/fi not_active IP Right Cessation
- 1989-08-01 EP EP89307788A patent/EP0353983B1/en not_active Expired - Lifetime
- 1989-08-01 DK DK377889A patent/DK169922B1/da not_active IP Right Cessation
- 1989-08-01 PT PT91336A patent/PT91336B/pt not_active IP Right Cessation
1996
- 1996-06-27 GR GR960401718T patent/GR3020349T3/el unknown

Also Published As

Publication number	Publication date
JPH02160786A (ja)	1990-06-20
FI893634A0 (fi)	1989-08-01
AU631131B2 (en)	1992-11-19
EP0353983A3 (en)	1990-07-25
DK377889A (da)	1990-02-03
FI893634A7 (fi)	1990-02-03
DE68926553T2 (de)	1996-10-17
CA1336906C (en)	1995-09-05
NO169714B (no)	1992-04-21
PT91336B (pt)	1995-05-04
ATE138659T1 (de)	1996-06-15
FI92067C (fi)	1994-09-26
NZ230154A (en)	1991-10-25
EP0353983A2 (en)	1990-02-07
DE68926553D1 (de)	1996-07-04
IL91167A0 (en)	1990-03-19
GR3020349T3 (en)	1996-09-30
DK169922B1 (da)	1995-04-03
ES2088389T3 (es)	1996-08-16
AU3918689A (en)	1990-02-08
NO169714C (no)	1992-07-29
NO893101D0 (no)	1989-08-01
PT91336A (pt)	1990-03-08
FI92067B (fi)	1994-06-15
IL91167A (en)	1993-06-10
DK377889D0 (da)	1989-08-01
EP0353983B1 (en)	1996-05-29

Publication	Publication Date	Title
NO893101D0 (no)	1989-08-01	Fremgangsmaate for fremstilling av laktamderivater.
GB2209335B (en)	1991-05-29	Lactam derivatives
GB8904551D0 (en)	1989-04-12	Chemical compounds
ATE152109T1 (de)	1997-05-15	Verfahren zur herstellung substituierter benzofuranderivate
EP0276163A3 (en)	1988-11-30	Indole derivatives
DK0458624T3 (da)	1998-10-19	Fremgangsmåde til fremstilling af lactamderivater
EP0327307A3 (en)	1990-08-01	Tricyclic ketone derivatives having a 5-HT3 antagonist activity
NO891608D0 (no)	1989-04-19	Heterotetracykliske laktamderivater.
MY102646A (en)	1992-08-17	Tricyclic ketones
MY106232A (en)	1995-04-29	Lactam derivatives
FI892415A0 (fi)	1989-05-19	Tricykliska ketoner.
MY103831A (en)	1993-09-30	Lactam derivatives.
UA35545C2 (uk)	2001-04-16	Спосіб одержання похідних 4-оксохіноліну або хромону
FI884049A7 (fi)	1989-03-04	Laktamderivat.